Last reviewed · How we verify

NCT04645563

Using Whatsapp for the Consultation

Completed Last updated 27 November 2020
What this trial tests

trial testing Sending thorax ct video images via smartphone applications in Covid-19 in 144 participants. Completed in 31 May 2020.

Timeline
11 March 2020
Primary endpoint
30 May 2020
31 May 2020

Quick facts

Lead sponsorKafkas University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment144
Start date11 March 2020
Primary completion30 May 2020
Estimated completion31 May 2020
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Kafkas University

Who can join

18 and older, any sex, with Covid-19. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Telephone, internet-connected devices (phablet, pc), chat platforms, mobile applications (Skype, Facebook messenger, Whatsapp, to name a few) can be exploited for telemedicine applications. Whatsapp and similar applications are widely used to facilitate clinical communication between physicians, too. Moreover, Whatsapp is used between ED physicians and consultant physicians during ED consultations in which medical information is exchanged. This platform is regarded as a useful application in the consultation of dermatological and orthopaedic cases. Preventing the overcrowding in the ED is key to reducing the transmission risk, and teleconsulting practice is thought to be effective in the diagnosis, treatment and reduction of the risk of disease transmission, most notably in the Covid-19 pandemic process. Video consulting is highly recommended in some countries on the grounds that it is likely to reduce the risk of transmission. Whatsapp-like applications are one of the video-consulting platforms assumed to reduce the risk of contamination by minimizing the patient-doctor contact. This study thus sets out to investigate the effect of Whatsapp video consultation upon patient admission and discharge times in comparison to bedside consultation in the evaluation of potential Covid-19 patients visiting the Covid-19 outpatient clinic during the pandemic period. The subjects who presented to ED Covid-19 outpatient clinic between March 11, 2020 and May 31, 2020 and for whom an infectious diseases (ID) physician was consulted (via Whatsapp or at bedside) will be included in the study in accordance with the inclusion and exclusion criteria. Eventually, 54 patients whose consultations were made via Whatsapp and 90 patients whose consultations were made at bedside will be in this study.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Use of WhatsApp for Polyclinic Consultation of Suspected Patients With COVID-19: Retrospective Case Control Study.
    Sabırlı R, Karsli E, Canacik O, Ercin D, et al · · 2020 · cited 11× · PMID 33276318 · DOI 10.2196/22874

Verify or expand the search:

Other recruiting trials for Covid-19

Currently open trials in the same condition.

Other Kafkas University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04645563.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing